GO:0006309 apoptotic DNA fragmentation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006309 apoptotic DNA fragmentation is the biological process in which DNA is cleaved during apoptosis, typically in two stages: initial cleavage into ~50 kbp fragments followed by internucleosomal cleavage to ~200 bp fragments.
• The major apoptotic nuclease responsible for this process is DNA fragmentation factor 40 (DFF40/CAD), which is activated by caspase-3-mediated cleavage of its inhibitor DFF45/ICAD.
• Apoptotic DNA fragmentation is a hallmark of apoptosis and is widely detected by TUNEL assays and ultrastructural methods.
• Dysregulation of apoptotic DNA fragmentation contributes to cancer, neurodegenerative diseases, and male infertility, making it a key area of biomedical research.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of genes involved in apoptotic DNA fragmentation.
• Understanding GO:0006309 supports development of therapeutics targeting apoptosis-related diseases and improves diagnostic assays for DNA fragmentation.
Description
Apoptotic DNA fragmentation (GO:0006309) is a fundamental biological process that occurs during programmed cell death, characterized by the cleavage of DNA into distinct fragments. This process is essential for proper tissue homeostasis and development, as it ensures the orderly removal of damaged or unwanted cells. Researchers study this term to understand the molecular mechanisms of apoptosis, identify therapeutic targets for diseases such as cancer and neurodegeneration, and develop reliable detection methods for cell death. The process is highly regulated and involves specific nucleases and caspases, making it a rich area for genetic and pharmacological investigation. Given its central role in cell death pathways, apoptotic DNA fragmentation is a critical focus in biomedical research, with implications for diagnostics and treatment strategies.
apoptotic DNA fragmentation At A Glance
| GO ID | GO:0006309 |
|---|---|
| GO term | apoptotic DNA fragmentation |
| Ontology | biological_process |
| Synonym | chromatinolysis; DNA catabolic process during apoptosis; DNA catabolism during apoptosis; DNA fragmentation; DNA fragmentation involved in apoptotic nuclear change; endonucleolytic DNA catabolic process involved in apoptosis |
| Major function | Cleavage of DNA during apoptosis into ~50 kbp and ~200 bp fragments |
| Key enzymes | DFF40/CAD, DFF45/ICAD, caspase-3 |
| Detection methods | TUNEL assay, ultrastructural analysis |
| Related diseases | Cancer, neurodegeneration, male infertility |
What Is GO:0006309?
Apoptotic DNA fragmentation (GO:0006309) refers to the cleavage of DNA that occurs during apoptosis, usually in two stages: first, DNA is cut into large fragments of about 50 kbp, and then further cleaved between nucleosomes to produce fragments of approximately 200 bp. This process is mediated by specific nucleases and is a hallmark of apoptotic cell death.
Why Is apoptotic DNA fragmentation Important in Cell Biology?
Apoptotic DNA fragmentation is a critical process for maintaining tissue homeostasis and preventing diseases such as cancer, where apoptosis is often evaded. It is also a key marker of apoptosis in research and diagnostics, enabling the assessment of cell death in various experimental and clinical settings. Understanding its regulation provides insights into therapeutic strategies for conditions characterized by excessive or insufficient apoptosis.
• Serves as a hallmark of apoptosis, aiding in the detection and quantification of cell death.
• Essential for proper embryonic development and tissue remodeling.
• Dysregulation is linked to cancer progression and resistance to therapy.
• Implicated in neurodegenerative diseases where excessive apoptosis occurs.
• Associated with male infertility due to abnormal sperm DNA fragmentation.
• Provides targets for therapeutic intervention in apoptosis-related disorders.
• Enables researchers to study caspase activation and nuclease function.
• Facilitates the development of diagnostic assays like TUNEL.
• Helps understand the mechanisms of chemotherapy-induced cell death.
• Supports basic research in cell biology and genetics.
What Happens During apoptotic DNA fragmentation?
Initiation by Caspase Activation
In simple terms: The process starts when caspases, especially caspase-3, are activated.
Apoptotic DNA fragmentation is initiated by the activation of executioner caspases, particularly caspase-3, which cleave key substrates to trigger DNA cleavage. Caspase-3 activation is a pivotal step that leads to the activation of downstream nucleases.
Activation of DFF40/CAD
In simple terms: Caspase-3 cuts DFF45/ICAD, releasing the active nuclease DFF40/CAD.
Caspase-3 cleaves the inhibitor DFF45/ICAD, liberating the active nuclease DFF40/CAD, which then translocates to the nucleus to cleave DNA. This activation is essential for the characteristic DNA fragmentation pattern.
Two-Stage DNA Cleavage
In simple terms: DNA is first cut into large pieces, then into smaller fragments.
DFF40/CAD first cleaves DNA into ~50 kbp fragments, and subsequently performs internucleosomal cleavage to generate ~200 bp fragments. This two-stage process is a defining feature of apoptotic DNA fragmentation.
Nuclear Changes and Chromatinolysis
In simple terms: The nucleus undergoes structural changes as DNA is degraded.
During apoptotic DNA fragmentation, the nucleus exhibits chromatin condensation and eventual disintegration, a process termed chromatinolysis. These morphological changes are detectable by ultrastructural analysis.
Detection of DNA Fragmentation
In simple terms: Scientists use TUNEL to see DNA breaks.
The TUNEL assay is widely used to detect DNA fragmentation by labeling free 3'-OH ends in apoptotic cells. This method allows visualization and quantification of apoptotic DNA fragmentation in situ.
Key Genes Involved in GO:0006309 apoptotic DNA fragmentation
Key genes and proteins involved in apoptotic DNA fragmentation include nucleases, caspases, and their regulators.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DFF40/CAD (DFFB) | Major apoptotic nuclease that cleaves DNA | Central to DNA fragmentation; target for knockout studies |
| DFF45/ICAD (DFFA) | Inhibitor of DFF40; cleaved by caspase-3 | Regulates nuclease activity; knockout models |
| CASP3 | Executioner caspase that activates DFF40 | Key initiator; knockout and point mutation studies |
| CASP7 | Caspase involved in apoptosis | Potential redundant role; research models |
| CASP8 | Initiator caspase in extrinsic pathway | Upstream regulator; knockout models |
| CASP9 | Initiator caspase in intrinsic pathway | Upstream regulator; knockout models |
| APAF1 | Apoptosome component activating caspase-9 | Essential for intrinsic apoptosis; KO models |
| BAX | Pro-apoptotic Bcl-2 family member | Regulates mitochondrial pathway; overexpression models |
| BAK | Pro-apoptotic Bcl-2 family member | Redundant with BAX; double KO studies |
| BCL2 | Anti-apoptotic protein | Inhibits apoptosis; overexpression models |
| TP53 | Tumor suppressor inducing apoptosis | Frequently mutated in cancer; KO models |
| ENDOG | Endonuclease G, mitochondrial nuclease | Caspase-independent DNA fragmentation; KO models |
| AIFM1 | Apoptosis-inducing factor | Caspase-independent pathway; KO models |
| DNASE1L3 | DNase involved in DNA fragmentation | Alternative nuclease; KO models |
| DNASE2 | Lysosomal DNase | Role in DNA degradation; KO models |
| HMGB1 | Chromatin protein released during apoptosis | Marker of apoptosis; research models |
| H2AFX | Histone variant involved in DNA damage response | Phosphorylation in apoptosis; KO models |
| TOP2A | Topoisomerase II | DNA cleavage during apoptosis; inhibitor studies |
How Is apoptotic DNA fragmentation Regulated?
Apoptotic DNA fragmentation is tightly regulated by the balance of pro- and anti-apoptotic signals, including Bcl-2 family proteins and caspase activation. The process can be modulated by cellular stress, DNA damage, and developmental cues. DFF40/ICAD activity is controlled by caspase-3-mediated cleavage, ensuring that DNA fragmentation occurs only during apoptosis.
apoptotic DNA fragmentation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Cancer (impaired apoptosis) | Knockout and point mutation models |
| BCL2 | Cancer (apoptosis resistance) | Overexpression models |
| DFFB | Cancer (altered DNA fragmentation) | Knockout models |
| DFFA | Cancer (dysregulated nuclease) | Knockout and knock-in models |
| CASP3 | Neurodegeneration (excessive apoptosis) | Knockout models |
Cancer
Evasion of apoptosis, including defective DNA fragmentation, is a hallmark of cancer, contributing to tumor survival and resistance to therapy. Mutations in TP53 or overexpression of anti-apoptotic proteins like BCL2 can impair apoptotic DNA fragmentation.
Neurodegenerative Diseases
Excessive apoptosis and DNA fragmentation are implicated in neuronal loss in conditions such as Alzheimer's and Parkinson's diseases. Understanding the regulation of apoptotic DNA fragmentation may offer therapeutic targets.
Male Infertility
Abnormal sperm DNA fragmentation is associated with male infertility, and cryopreservation can affect DNA fragmentation and apoptotic markers. Assessing apoptotic DNA fragmentation in sperm is relevant for fertility diagnostics.
From apoptotic DNA fragmentation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does DFF40/CAD knockout abolish apoptotic DNA fragmentation? | DFFB knockout cell line |
| How does caspase-3 cleavage of DFF45 regulate nuclease activity? | Point mutation in DFFA cleavage site |
| Can overexpression of BCL2 inhibit DNA fragmentation? | BCL2 overexpression cell line |
| What is the role of TP53 in apoptotic DNA fragmentation? | TP53 knockout and point mutation models |
| Does ENDOG contribute to caspase-independent DNA fragmentation? | ENDOG knockout model |
| Can we tag DFF40 to visualize its nuclear translocation? | Tagged knock-in of DFFB |
How to Study the apoptotic DNA fragmentation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TUNEL | DNA fragmentation (3'-OH ends) | Detection of apoptosis in cells and tissues |
| Electron microscopy | Ultrastructural changes | Visualization of chromatinolysis |
| Sperm DNA fragmentation assay | DNA breaks in sperm | Male fertility assessment |
| Western blot | Protein cleavage (e.g., DFF45) | Caspase activation studies |
| Immunofluorescence | Nuclear translocation of DFF40 | Localization studies |
| CRISPR knockout | Gene function | Causal studies of apoptotic genes |
| Flow cytometry | Apoptotic cell quantification | High-throughput screening |
TUNEL Assay
The TUNEL assay detects DNA fragmentation by labeling free 3'-OH ends, allowing quantification of apoptotic cells. It is widely used in both research and clinical settings.
Ultrastructural Analysis
Electron microscopy can reveal chromatin condensation and DNA fragmentation at the ultrastructural level, providing detailed morphological evidence of apoptosis.
Sperm DNA Fragmentation Assays
Sperm DNA fragmentation can be assessed using specialized assays, which are important for evaluating male fertility and the effects of cryopreservation.
Genetic Knockout and Knock-in Models
CRISPR-based knockout and knock-in models enable functional studies of genes involved in apoptotic DNA fragmentation, such as DFFB and CASP3.
How CRISPR Can Be Used to Study GO:0006309 apoptotic DNA fragmentation
Knockout
CRISPR knockout of DFFB or CASP3 can abolish apoptotic DNA fragmentation, providing direct evidence of their essential roles.
Point Mutation
Introducing point mutations in caspase cleavage sites of DFF45 can prevent its cleavage and block DFF40 activation, elucidating regulatory mechanisms.
Knock-in
Tagged knock-in of DFFB allows real-time visualization of DFF40 nuclear translocation during apoptosis.
Overexpression
Overexpression of anti-apoptotic BCL2 or mutant TP53 can inhibit apoptotic DNA fragmentation, modeling cancer resistance.
How EDITGENE Supports apoptotic DNA fragmentation Research
Researchers studying apoptotic DNA fragmentation-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides tailored CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for apoptotic DNA fragmentation research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| DFFB Knockout HEK293 Cell Line | EDJ-KQ1302 | Human | 1677 | Details Get a Quote |
| FOXL2 Knockout HEK293 Cell Line | EDJ-KQ2444 | Human | 668 | Details Get a Quote |
| DNASE2 Knockout HEK293 Cell Line | EDJ-KQ3096 | Human | 1777 | Details Get a Quote |
| DFFA Knockout HEK293 Cell Line | EDJ-KQ4438 | Human | 1676 | Details Get a Quote |
| DNASE1L3 Knockout HEK293 Cell Line | EDJ-KQ4460 | Human | 1776 | Details Get a Quote |
| EXOG Knockout HEK293 Cell Line | EDJ-KQ6834 | Human | 9941 | Details Get a Quote |
| CECR2 Knockout HEK293 Cell Line | EDJ-KQ8783 | Human | 27443 | Details Get a Quote |
| DNASE2B Knockout HEK293 Cell Line | EDJ-KQ13192 | Human | 58511 | Details Get a Quote |
| DFFB Knockout A-549 Cell Line | EDJ-KQ22016 | Human | 1677 | Details Get a Quote |
| DFFB Knockout HCT 116 Cell Line | EDJ-KQ22018 | Human | 1677 | Details Get a Quote |
| DFFB Knockout HeLa Cell Line | EDJ-KQ22019 | Human | 1677 | Details Get a Quote |
| FOXL2 Knockout A-549 Cell Line | EDJ-KQ22960 | Human | 668 | Details Get a Quote |
| FOXL2 Knockout HeLa Cell Line | EDJ-KQ22961 | Human | 668 | Details Get a Quote |
| DNASE2 Knockout A-549 Cell Line | EDJ-KQ23038 | Human | 1777 | Details Get a Quote |
| DFFA Knockout A-549 Cell Line | EDJ-KQ26986 | Human | 1676 | Details Get a Quote |
Displaying Records 1 To 15 Of 41 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About apoptotic DNA fragmentation
What is apoptotic DNA fragmentation?
Apoptotic DNA fragmentation is the cleavage of DNA during apoptosis, typically into ~50 kbp and ~200 bp fragments, mediated by nucleases like DFF40/CAD.
What genes are involved in apoptotic DNA fragmentation?
Key genes include DFFB (DFF40/CAD), DFFA (DFF45/ICAD), CASP3, and TP53, among others.
How is apoptotic DNA fragmentation detected?
It is commonly detected by TUNEL assay, which labels DNA breaks, and by ultrastructural analysis.
What is the role of caspase-3 in apoptotic DNA fragmentation?
Caspase-3 activates DFF40/CAD by cleaving its inhibitor DFF45/ICAD, leading to DNA cleavage.
Can apoptotic DNA fragmentation be measured in sperm?
Yes, sperm DNA fragmentation assays are used to assess male fertility and the effects of cryopreservation.
What diseases are associated with abnormal apoptotic DNA fragmentation?
Cancer, neurodegenerative diseases, and male infertility are linked to dysregulated apoptotic DNA fragmentation.
How do CRISPR models help study apoptotic DNA fragmentation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes involved in the process.
What is DFF40/CAD?
DFF40/CAD is the major apoptotic nuclease that cleaves DNA during apoptosis, activated by caspase-3.
Is apoptotic DNA fragmentation always caspase-dependent?
While caspase-dependent pathways are primary, caspase-independent mechanisms involving ENDOG or AIF can also contribute.
What are the two stages of apoptotic DNA fragmentation?
The first stage produces ~50 kbp fragments, and the second stage yields ~200 bp internucleosomal fragments.
Conclusion
Apoptotic DNA fragmentation (GO:0006309) is a central event in apoptosis, essential for tissue homeostasis and implicated in numerous diseases. Understanding its molecular players and regulation offers opportunities for therapeutic intervention and diagnostic development. EDITGENE provides advanced CRISPR tools to accelerate research in this field.
References
- 1. Nagata S. 2000. Apoptotic DNA fragmentation.. Exp Cell Res 256(1):12-8 PMID: 10739646
- 2. Zhang J et al.. 2002. Apoptotic DNA fragmentation and tissue homeostasis.. Trends Cell Biol 12(2):84-9 PMID: 11849972
- 3. Porter AG et al.. 1999. Emerging roles of caspase-3 in apoptosis.. Cell Death Differ 6(2):99-104 PMID: 10200555
- 4. Ha HJ et al.. 2022. Molecular basis of apoptotic DNA fragmentation by DFF40.. Cell Death Dis 13(3):198 PMID: 35236824
- 5. Widlak P et al.. 2009. Roles of the major apoptotic nuclease-DNA fragmentation factor-in biology and disease.. Cell Mol Life Sci 66(2):263-74 PMID: 18810317
- 6. Abou-El-Naga AM et al.. 2025. Impact of cryopreservation agents on sperm quality, DNA fragmentation, and apoptotic markers in fertile and infertile males.. Sci Rep 15(1):30072 PMID: 40820177
- 7. Crowley LC et al.. 2016. Detection of DNA Fragmentation in Apoptotic Cells by TUNEL.. Cold Spring Harb Protoc 2016(10) PMID: 27698233
- 8. Burattini S et al.. 2009. Apoptotic DNA fragmentation can be revealed in situ: an ultrastructural approach.. Microsc Res Tech 72(12):913-23 PMID: 19484747
